EGETIS THERAPEUTICS Trademark 79312278

Trademark: 79312278

Word

EGETIS THERAPEUTICS

Status

Dead

Status Code

401

Status Date

Friday, May 20, 2022

Serial Number

79312278

Mark Type

4000

Filing Date

Tuesday, March 23, 2021

Abandoned Date

Saturday, May 14, 2022

Trademark Owner History

Egetis Therapeutics AB

Classifications

5 Medical and veterinary preparations and substances, namely, for the treatment of acetaminophen/paracetamol over dose, MCT8 deficiency, RTHb, oncological, neurological, endocrinological, metabolic, hematological, eye, autoimmune and inflammatory related diseases; vaccines; sanitary preparations for medical use; dietetic and nutritional preparations for medical use; diagnostic preparations for medical use; chemical reagents for medical use; diagnostic tests for medical use

42 Medical research; biological and chemical research; research and development of new medicines and medical preparations; medical and chemical laboratories; scientific and industrial research relating to medicinal or veterinary practice; diagnostic and screening services relating to medicinal or veterinary research and development; informational services relating to medicinal or veterinary research and development

Trademark Events

Mar 6, 2022

Notification Of Effect Of Cancellation Of Intl Reg Mailed

Mar 5, 2022

Death Of International Registration

Dec 19, 2021

Refusal Processed By Ib

Dec 2, 2021

Non-Final Action Mailed - Refusal Sent To Ib

Dec 2, 2021

Refusal Processed By Mpu

Nov 2, 2021

Non-Final Action (Ib Refusal) Prepared For Review

Nov 1, 2021

Non-Final Action Written

Oct 28, 2021

Assigned To Examiner

Jun 11, 2021

Application Filing Receipt Mailed

Jun 7, 2021

New Application Office Supplied Data Entered In Tram

Jun 5, 2021

Limitation From Original Application Entered

Jun 3, 2021

Sn Assigned For Sect 66a Appl From Ib

PSS

REWARDS FOR ALL

Trademark Alertz updated from USPTO on 2030-01-24